GSK plc reported that on January 10, 2025, several executives, including CEO Emma Walmsley and CFO Julie Brown, acquired 180 ordinary shares at a price of £13.4894 as part of the Company's Share Reward Plan following the reinvestment of dividends paid on January 9, 2025.